{"id":"https://openalex.org/W2104644381","doi":"https://doi.org/10.2165/00044011-200525030-00006","title":"Bioequivalence and Rapid Absorption of Zolmitriptan Nasal Spray Compared with Oral Tablets in Healthy Japanese Subjects","display_name":"Bioequivalence and Rapid Absorption of Zolmitriptan Nasal Spray Compared with Oral Tablets in Healthy Japanese Subjects","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2104644381","doi":"https://doi.org/10.2165/00044011-200525030-00006","mag":"2104644381","pmid":"https://pubmed.ncbi.nlm.nih.gov/17523769"},"language":"en","primary_location":{"id":"doi:10.2165/00044011-200525030-00006","doi":"https://doi.org/10.2165/00044011-200525030-00006","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00044011-200525030-00006","pdf_url":null,"source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041802301","display_name":"Naoto Uemura","orcid":"https://orcid.org/0000-0002-3722-8979","observed_orcids":["https://orcid.org/0000-0002-3722-8979"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Naoto Uemura","raw_affiliation_strings":["Consultant for Japan Clinical Pharmacology Laboratories, Ltd, Tokyo, Japan","Japan Clinical Pharmacology Laboratories Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant for Japan Clinical Pharmacology Laboratories, Ltd, Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tatsuo Onishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128490","display_name":"AstraZeneca (Japan)","ror":"https://ror.org/047k23798","country_code":"JP","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210128490"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuo Onishi","raw_affiliation_strings":["AstraZeneca KK, Osaka, Japan","AstraZeneca KK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca KK, Osaka, Japan","institution_ids":["https://openalex.org/I4210128490"]},{"raw_affiliation_string":"AstraZeneca KK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063458866","display_name":"Akira Mitaniyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253747","display_name":"NIIZASHIKI Central General Hospital","ror":"https://ror.org/011rjky44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253747"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akira Mitaniyama","raw_affiliation_strings":["Niiza Shiki Central General Hospital, Saitama, Japan","Niiza Shiki Central General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niiza Shiki Central General Hospital, Saitama, Japan","institution_ids":["https://openalex.org/I4405253747"]},{"raw_affiliation_string":"Niiza Shiki Central General Hospital","institution_ids":["https://openalex.org/I4405253747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054367448","display_name":"Takeshi Kaneko","orcid":"https://orcid.org/0000-0001-9292-307X","observed_orcids":["https://orcid.org/0000-0001-9292-307X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takeshi Kaneko","raw_affiliation_strings":["Japan Clinical Pharmacology Laboratories Ltd, View Tower Hachioji 4F, 8-1 Yoka-machi, Hachioji-shi, Tokyo, 192-0071, Japan","Japan Clinical Pharmacology Laboratories Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd, View Tower Hachioji 4F, 8-1 Yoka-machi, Hachioji-shi, Tokyo, 192-0071, Japan","institution_ids":[]},{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060929637","display_name":"Kohji Ninomiya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kohji Ninomiya","raw_affiliation_strings":["Japan Clinical Pharmacology Laboratories Ltd, View Tower Hachioji 4F, 8-1 Yoka-machi, Hachioji-shi, Tokyo, 192-0071, Japan","Japan Clinical Pharmacology Laboratories Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd, View Tower Hachioji 4F, 8-1 Yoka-machi, Hachioji-shi, Tokyo, 192-0071, Japan","institution_ids":[]},{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103075935","display_name":"K\u014dichi Nakamura","orcid":"https://orcid.org/0000-0003-2330-7032","observed_orcids":["https://orcid.org/0000-0003-2330-7032","https://orcid.org/0009-0006-3990-7429"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koichi Nakamura","raw_affiliation_strings":["Japan Clinical Pharmacology Laboratories Ltd, View Tower Hachioji 4F, 8-1 Yoka-machi, Hachioji-shi, Tokyo, 192-0071, Japan","Japan Clinical Pharmacology Laboratories Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd, View Tower Hachioji 4F, 8-1 Yoka-machi, Hachioji-shi, Tokyo, 192-0071, Japan","institution_ids":[]},{"raw_affiliation_string":"Japan Clinical Pharmacology Laboratories Ltd","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071962848","display_name":"Masao Tateno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253747","display_name":"NIIZASHIKI Central General Hospital","ror":"https://ror.org/011rjky44","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405253747"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masao Tateno","raw_affiliation_strings":["Niiza Shiki Central General Hospital, Saitama, Japan","Niiza Shiki Central General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niiza Shiki Central General Hospital, Saitama, Japan","institution_ids":["https://openalex.org/I4405253747"]},{"raw_affiliation_string":"Niiza Shiki Central General Hospital","institution_ids":["https://openalex.org/I4405253747"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5041802301"],"corresponding_institution_ids":[],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":0.6414,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.68125427,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"25","issue":"3","first_page":"199","last_page":"208"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zolmitriptan","display_name":"zolmitriptan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nasal-spray","display_name":"nasal spray","score":0.8190000057220459},{"id":"https://openalex.org/keywords/oral-tablets","display_name":"oral tablets","score":0.9139999747276306},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9649999737739563},{"id":"https://openalex.org/keywords/migraine-treatment","display_name":"migraine treatment","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2779085531","wikidata":"https://www.wikidata.org/wiki/Q218820","display_name":"Zolmitriptan","level":5,"score":0.9759043455123901},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8830184936523438},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.7604423761367798},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7367116808891296},{"id":"https://openalex.org/C2780973058","wikidata":"https://www.wikidata.org/wiki/Q1755275","display_name":"Nasal spray","level":3,"score":0.7285659313201904},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.6518313884735107},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5480577349662781},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5388848781585693},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5237386226654053},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5026745796203613},{"id":"https://openalex.org/C46821324","wikidata":"https://www.wikidata.org/wiki/Q7094540","display_name":"Onset of action","level":2,"score":0.46828481554985046},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.45546966791152954},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44642236828804016},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.4290223717689514},{"id":"https://openalex.org/C2778871607","wikidata":"https://www.wikidata.org/wiki/Q416978","display_name":"Sumatriptan","level":4,"score":0.3520185947418213},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22844061255455017},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17887070775032043},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.06004071235656738},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.053520917892456055},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2165/00044011-200525030-00006","doi":"https://doi.org/10.2165/00044011-200525030-00006","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00044011-200525030-00006","pdf_url":null,"source":{"id":"https://openalex.org/S138241747","display_name":"Clinical Drug Investigation","issn_l":"0114-2402","issn":["0114-2402","1173-2563","1179-1918","2196-4920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Drug Investigation","raw_type":"journal-article"},{"id":"pmid:17523769","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17523769","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical drug investigation","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1916831760","https://openalex.org/W1978835643","https://openalex.org/W1992472429","https://openalex.org/W2004599966","https://openalex.org/W2010385322","https://openalex.org/W2030786505","https://openalex.org/W2032083067","https://openalex.org/W2032164227","https://openalex.org/W2041652427","https://openalex.org/W2042852239","https://openalex.org/W2045150916","https://openalex.org/W2047955071","https://openalex.org/W2071760228","https://openalex.org/W2078764239","https://openalex.org/W2120236823","https://openalex.org/W2132788265","https://openalex.org/W2134552151","https://openalex.org/W2146295084","https://openalex.org/W2146907577"],"related_works":["https://openalex.org/W2010385322","https://openalex.org/W2010310544","https://openalex.org/W2001032397","https://openalex.org/W2085950561","https://openalex.org/W23896796","https://openalex.org/W2047955071","https://openalex.org/W4247691111","https://openalex.org/W2041652427","https://openalex.org/W1978912984","https://openalex.org/W1983890482"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}